Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Session I: Cancer Immunoediting and Cancer and Inflammation

Molecules regulating the immunosurveillance of tissues

Adrian Hayday, Mike Girardi, Bob Tigelaar, Julie Lewis, Martin Woodward, Jessica Strid and Susannah Barbee
Adrian Hayday
1King's College School of Medicine at Guy's Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Girardi
2Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bob Tigelaar
2Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Lewis
2Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Woodward
1King's College School of Medicine at Guy's Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Strid
1King's College School of Medicine at Guy's Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susannah Barbee
1King's College School of Medicine at Guy's Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published January 2008
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Very many of the body's T cells are not conventionally MHC-peptide restricted, but often compose oligoclonal repertoires constitutively associated with tissues. It was proposed 20 years ago that these cells may respond rapidly to generic molecular markers of tissue dysregulation, and consistent with this, we have now shown that epidermal gamma delta T cells quickly respond to the upregulated expression in keratinocytes of a single stress-associated MHC-related molecule, Rae-1, and that this leads to a several downstream events including an unanticipated tissue infiltration by NKT cells. The functional orthologues of Rae-1 in humans include the MICA gene that is strongly implicated in the regulation of human responses to viral infection, inflammation, and to malignant transformation. Indeed, MICA is a highly polymorphic gene, with >50 alleles described. The finding that skin-associated T cells respond to Rae-1 upregulation suggests they may play a pivotal role in immunosurveillance, upstream of DC or other cells. Current studies aim to define the consequences of this T cell driven immunosurveillance under different circumstances.

The early activation of Rae-1 is a common characteristic of skin carcinogenesis that we have shown to be limited by the action of skin-associated gamma delta T cells, but only of the "wild type" / "canonical" repertoire. How specific repertoires of tissue-associated T cells form has long been a matter of speculation, but we recently helped identify a novel gene, Skint-1, that is the prototypic member of a novel family of immunoglobulin (Ig)-like genes that are specifically expressed in skin and thymus epithelium. The mechanism-of-action and the regulation of the Skint genes is under investigation, with its potential to cast light on epithelial-T cell interactions. We are also studying the immunological roles of the closest sequence-homologs to Skint-1, namely the Btnl genes that also encode Ig superfamily molecules expressed by epithelial cells, but specifically in the gut rather than the skin. The gut is a key area of immunosurveillance, where we remain largely ignorant of immune interactions of epithelial cells. In sum, we wish to use animal models and biochemical and molecular techniques to better define the molecular basis and implications of epithelial-T cell cross-talk mediated by Skint, Btnl, and other related molecules. We have also commenced clinical translation of lessons learned to immunotherapy of carcinomas.

This abstract was published in Cancer Immunity, a Cancer Research Institute journal that ceased publication in 2013 and is now provided online in association with Cancer Immunology Research.

 

  • Copyright © 2008 by Adrian Hayday

References

  1. 1.
    1. Boyden LM,
    2. Lewis JM,
    3. Barbee SD,
    4. Bas A,
    5. Girardi M,
    6. Hayday AC,
    7. Tigelaar RE,
    8. Lifton RP
    . Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gamma delta T cells. Nat Genet 2008;40:656–662.pmid:18408721
    OpenUrlCrossRefPubMed
  2. 2.
    1. Strid J,
    2. Roberts SJ,
    3. Filler RB,
    4. Lewis JM,
    5. Kwong BY,
    6. Schpero W,
    7. Kaplan DH,
    8. Hayday AC,
    9. Girardi M
    . Acute NKG2D-ligand upregulation promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol 2008;9:146–154.pmid:18176566
    OpenUrlCrossRefPubMed
  3. 3.
    1. Dieli F,
    2. Vermijlen D,
    3. Fulfaro F,
    4. Caccamo N,
    5. Roberts A,
    6. Meraviglia S,
    7. Cicero G,
    8. Buccheri S,
    9. D'Asaro M,
    10. Gebbia N,
    11. Salerno A,
    12. Eberl M,
    13. Hayday AC
    . Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer - a clinical trial. Cancer Res 2007;67:7450–7457.pmid:17671215
    OpenUrlAbstract/FREE Full Text
  4. 4.
    1. Lewis JM,
    2. Girardi M,
    3. Roberts SJ,
    4. Barbee SD,
    5. Hayday AC,
    6. Tigelaar RE
    . Selection of the cutaneous intraepithelial γδ T cell repertoire by a thymic stromal determinant. Nat Immunol 2006;7:843–850.pmid:16829962
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Cancer Immunity Archive: 8 (Suppl 2)
January 2008
Volume 8, Issue Suppl 2
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Molecules regulating the immunosurveillance of tissues
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Molecules regulating the immunosurveillance of tissues
Adrian Hayday, Mike Girardi, Bob Tigelaar, Julie Lewis, Martin Woodward, Jessica Strid and Susannah Barbee
Cancer Immun January 1 2008 (8) (Suppl 2) 2;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Molecules regulating the immunosurveillance of tissues
Adrian Hayday, Mike Girardi, Bob Tigelaar, Julie Lewis, Martin Woodward, Jessica Strid and Susannah Barbee
Cancer Immun January 1 2008 (8) (Suppl 2) 2;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • References
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Shaping an efficient adaptive immune microenvironment in human cancer
  • Cancer immunoediting: Recent progress in elimination and equilibrium
  • Cancer immunoediting: Molecular pathways to possible novel therapeutic interventions
Show more Session I: Cancer Immunoediting and Cancer and Inflammation
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement